Related Experiment Videos
Cisplatin-induced encephalopathy and seizures
N Steeghs1, F E de Jongh, P A E Sillevis Smitt
1Department of Medical Oncology, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
Anti-Cancer Drugs
|July 11, 2003
Summary
Cisplatin chemotherapy can rarely cause encephalopathy with seizures. Physicians should monitor patients for this serious neurological complication.
Area of Science:
- Neuroscience
- Oncology
- Toxicology
Background:
- Cisplatin is a widely used chemotherapy agent.
- It is known to cause peripheral sensory neuropathy.
- Rarely, cisplatin can induce central nervous system toxicity, including encephalopathy.
Observation:
- This study describes three patients who developed cisplatin-induced encephalopathy with seizures and focal neurological signs.
- Two patients recovered fully, while one experienced refractory status epilepticus and died.
- Post-mortem examination revealed ischemic lesions and gliosis in the deceased patient.
Findings:
- Cisplatin encephalopathy is a rare but severe neurological complication of chemotherapy.
- Clinical presentation can include seizures and focal neurological deficits.
- Rechallenge with cisplatin can precipitate recurrent encephalopathy.
Implications:
- Oncologists and healthcare providers must be aware of this potential adverse effect.
- Prompt recognition and management are crucial for patient outcomes.
- Further research into the mechanisms of cisplatin neurotoxicity is warranted.